| TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call |
Globe Newswire |
04/17 |
16:10 |
| SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders |
Globe Newswire |
04/17 |
16:05 |
| Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types |
Globe Newswire |
04/17 |
16:01 |
| Hingham Savings Reports First Quarter 2026 Results |
Globe Newswire |
04/17 |
16:01 |
| New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer |
Globe Newswire |
04/17 |
16:01 |
| Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting |
Globe Newswire |
04/17 |
16:01 |
| Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 |
Globe Newswire |
04/17 |
16:01 |
| Long Beach City College Wins Regional Construction Awards for Campus Upgrades |
Globe Newswire |
04/17 |
15:58 |
| Genesis Revival Claims Evaluated: Analyzing the Pineal Gland Support Ingredients, Side Effects Risk and User Complaints |
Globe Newswire |
04/17 |
15:48 |
| Introspect Technology Adds New ATE-on-Bench Solution for LPDDR6, DDR6, and HBM Interfaces |
Globe Newswire |
04/17 |
15:35 |
| Action Target Announces Registration Is Open for 34th Annual Law Enforcement Training Camp (LETC) |
Globe Newswire |
04/17 |
15:19 |
| Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026 |
Globe Newswire |
04/17 |
15:15 |
| Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial |
Globe Newswire |
04/17 |
15:10 |
| Kairos Power Breaks Ground on Hermes 2 Demonstration Plant |
Globe Newswire |
04/17 |
15:06 |
| Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the American Association of Cancer Research Annual Meeting |
Globe Newswire |
04/17 |
15:00 |
| New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma |
Globe Newswire |
04/17 |
15:00 |
| PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma |
Globe Newswire |
04/17 |
15:00 |
| Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026 |
Globe Newswire |
04/17 |
15:00 |
| Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform |
Globe Newswire |
04/17 |
15:00 |
| Toll Brothers Announces Final Luxury Home for Sale at Freestone Station in Marietta, Georgia |
Globe Newswire |
04/17 |
14:45 |
| Unicoin Foundation Debuts, Aligning Social Impact with the Future of Responsible Crypto |
Globe Newswire |
04/17 |
14:44 |
| Bitcoin Mining vs AI Trading Bots: AriseAlpha Launches Free Automated Crypto and Stock Trading Platform (2026) |
Globe Newswire |
04/17 |
14:16 |
| 2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling |
Globe Newswire |
04/17 |
14:13 |
| BitsStrategy Launches an Automated AI Trading Bot to Simplify Smarter, Hands-Free Market Trading |
Globe Newswire |
04/17 |
14:00 |
| Opticore Eye Group Unveils New Contact Lens Program in Riverside, CA for 2026 |
Globe Newswire |
04/17 |
13:57 |
